SCHEMBL31411335

SCHEMBL31411335

CN(C)CCc1n[nH]c2ccc(F)c(F)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 4/20 0.38
▸ HTR2A P28223 3/20 0.38
▸ HTR2C P28335 3/20 0.38
▸ HTR1A P08908 3/20 0.38
▸ TAAR1 Q96RJ0 3/20 0.37
▸ WNT1 P04628 2/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ MPO P05164 2/20 0.35
▸ GPR84 Q9NQS5 1/20 0.35
▸ ADRA2A P08913 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ ADRA2C P18825 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ ITK Q08881 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP2K4 P45985 1/20 0.32
▸ MAPKAPK2 P49137 1/20 0.32
▸ MAPKAPK3 Q16644 1/20 0.32
▸ MAPK6 Q16659 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL31411451 0.89 HTR7 (0.41) HTR2BHTR2AHTR2CHTR1AWNT1
SCHEMBL31411322 0.87 HTR2A (0.39) HTR2BHTR2AHTR2CGPR84HTR7
SCHEMBL31411452 0.83 HTR1A (0.59) HTR2BHTR2AHTR2CHTR1AMPO
SCHEMBL31411367 0.83 HTR1A (0.40) HTR2BHTR2AHTR2CHTR1ATAAR1
SCHEMBL31411355 0.82 HTR2A (0.55) HTR2BHTR2AHTR2CHTR1ATAAR1
Fumaric Acid SCHEMBL31411314 0.78 HTR2A (0.33) HTR2BHTR2AHTR2CHTR1AWNT1
SCHEMBL31411365 0.74 HTR1A (0.41) HTR2BHTR2AHTR2CHTR1AWNT1
SCHEMBL31411361 0.74 HTR1A (0.39) HTR2AHTR1AWNT1DYRK1AMPO
SCHEMBL25297732 0.73 HTR2A (0.55) HTR2BHTR2AHTR2CHTR1AHTR7
SCHEMBL31411318 0.73 MPO (0.55) HTR2BHTR2AHTR2CTAAR1MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 — — US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 — — US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 — — US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB HTR2B 114/4885HTR2A 94/4885HTR2C 23/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB HTR2B 114/4885HTR2A 94/4885HTR2C 23/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB HTR2B 114/4885HTR2A 94/4885HTR2C 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback